Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients.

Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL.

Pediatr Blood Cancer. 2019 Dec;66(12):e27978. doi: 10.1002/pbc.27978. Epub 2019 Sep 5.

PMID:
31486593
2.

Pediatric and Young Adult Vulvovaginal Graft-versus-Host Disease.

Cizek SM, El-Bietar J, Rubinstein J, Dandoy C, Wallace GH, Nelson A, Khandelwal P, Myers KC, Hoefgen HR.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2408-2415. doi: 10.1016/j.bbmt.2019.07.015. Epub 2019 Jul 17.

PMID:
31325588
3.

Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry.

Walkup LL, Myers K, El-Bietar J, Nelson A, Willmering MM, Grimley M, Davies SM, Towe C, Woods JC.

Eur Respir J. 2019 May 2;53(5). pii: 1801779. doi: 10.1183/13993003.01779-2018. Print 2019 May.

4.

Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation.

Rotz SJ, Powell A, Myers KC, Taylor MD, Jefferies JL, Lane A, El-Bietar JA, Davies SM, Dandoy CE, Ryan TD.

Cardiol Young. 2019 Mar;29(3):338-343. doi: 10.1017/S104795111800238X. Epub 2019 Feb 12.

PMID:
30744727
5.

Multiple bloodstream infections in pediatric stem cell transplant recipients: A case series.

Grossmann L, Alonso PB, Nelson A, El-Bietar J, Myers KC, Lane A, Andersen H, Haslam D, Jodele S, Davies SM, Dandoy CE.

Pediatr Blood Cancer. 2018 Dec;65(12):e27388. doi: 10.1002/pbc.27388. Epub 2018 Aug 9.

PMID:
30094932
6.

Single Ultra-High-Dose Cholecalciferol to Prevent Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation.

Wallace G, Jodele S, Myers KC, Dandoy CE, El-Bietar J, Nelson A, Teusink-Cross A, Khandelwal P, Taggart C, Gordon CM, Davies SM, Howell JC.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1856-1860. doi: 10.1016/j.bbmt.2018.05.019. Epub 2018 May 18.

7.

Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.

Jones L, Dandoy C, Jodele S, Myers KC, Luchtman-Jones L, Quinn CT, Mullins E, El-Bietar J.

Bone Marrow Transplant. 2018 Apr;53(4):487-489. doi: 10.1038/s41409-017-0041-0. Epub 2018 Jan 12. No abstract available.

PMID:
29330401
8.

Oral health and hematopoietic stem cell transplantation: A longitudinal evaluation of the first 28 days.

Doss LM, Dandoy CE, Kramer K, Pate A, Flesch L, El-Bietar J, Lane A, Davies SM, Thikkurissy S.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26773. Epub 2017 Aug 26.

PMID:
28843053
9.

A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy.

Warren M, Jodele S, Dandoy C, Myers KC, Wallace G, Nelson A, El-Bietar J.

Arch Pathol Lab Med. 2017 Nov;141(11):1558-1566. doi: 10.5858/arpa.2016-0599-RA. Epub 2017 Aug 10. Review.

PMID:
28795840
10.

Long-term systolic function in children and young adults after hematopoietic stem cell transplant.

Rotz SJ, Dandoy CE, Taylor MD, Jodele S, Jefferies JL, Lane A, El-Bietar JA, Powell AW, Davies SM, Ryan TD.

Bone Marrow Transplant. 2017 Oct;52(10):1443-1447. doi: 10.1038/bmt.2017.162. Epub 2017 Jul 17.

PMID:
28714947
11.

Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant.

Rotz SJ, Ryan TD, Hlavaty J, George SA, El-Bietar J, Dandoy CE.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26600. Epub 2017 Apr 28. Review.

PMID:
28453909
12.

The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults.

Rotz SJ, Ryan TD, Jodele S, Jefferies JL, Lane A, Pate A, Hirsch R, Hlavaty J, Levesque AE, Taylor MD, Cash M, Myers KC, El-Bietar JA, Davies SM, Dandoy CE.

Bone Marrow Transplant. 2017 Aug;52(8):1171-1179. doi: 10.1038/bmt.2017.62. Epub 2017 Apr 10.

PMID:
28394368
13.

Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

Khandelwal P, Teusink-Cross A, Davies SM, Nelson AS, Dandoy CE, El-Bietar J, Marsh RA, Kumar AR, Grimley MS, Jodele S, Myers KC.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1122-1127. doi: 10.1016/j.bbmt.2017.03.029. Epub 2017 Mar 23.

14.

Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients.

Dandoy CE, Jodele S, Paff Z, Hirsch R, Ryan TD, Jefferies JL, Cash M, Rotz S, Pate A, Taylor MD, El-Bietar J, Myers KC, Wallace G, Nelson A, Grimley M, Pfeiffer T, Lane A, Davies SM, Chima RS.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26513. Epub 2017 Mar 8.

PMID:
28271596
15.

Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series.

Pfeiffer TM, Rotz SJ, Ryan TD, Hirsch R, Taylor M, Chima R, Pate A, Hlavaty J, Grimley M, Myers K, El-Bietar J, Davies SM, Jodele S, Dandoy C.

Bone Marrow Transplant. 2017 Apr;52(4):630-633. doi: 10.1038/bmt.2016.331. Epub 2016 Dec 19. No abstract available.

16.

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

Khandelwal P, Emoto C, Fukuda T, Vinks AA, Neumeier L, Dandoy CE, El-Bietar J, Chandra S, Davies SM, Bleesing JJ, Jordan MB, Mehta PA, Jodele S, Grimley MS, Kumar A, Myers KC, Marsh RA.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2220-2225. doi: 10.1016/j.bbmt.2016.09.016. Epub 2016 Sep 21.

17.

Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients.

Teusink-Cross A, Davies SM, Danziger-Isakov L, El-Bietar J, Grimley MS.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1904-1906. doi: 10.1016/j.bbmt.2016.07.005. Epub 2016 Jul 12.

18.

Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.

Dandoy CE, Haslam D, Lane A, Jodele S, Demmel K, El-Bietar J, Flesch L, Myers KC, Pate A, Rotz S, Daniels P, Wallace G, Nelson A, Waters H, Connelly B, Davies SM.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1671-1677. doi: 10.1016/j.bbmt.2016.06.002. Epub 2016 Jun 13.

19.

RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation.

El-Bietar J, Nelson A, Wallace G, Dandoy C, Jodele S, Myers KC, Teusink A, Lane A, Davies SM, Danziger-Isakov L.

Bone Marrow Transplant. 2016 Oct;51(10):1382-1384. doi: 10.1038/bmt.2016.124. Epub 2016 May 16. No abstract available.

20.

New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, Laskin BL.

Transfus Apher Sci. 2016 Apr;54(2):181-90. doi: 10.1016/j.transci.2016.04.007. Epub 2016 Apr 25. Review.

21.

Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.

Jodele S, Dandoy CE, Danziger-Isakov L, Myers KC, El-Bietar J, Nelson A, Wallace G, Teusink-Cross A, Davies SM.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1337-1340. doi: 10.1016/j.bbmt.2016.03.032. Epub 2016 Apr 7.

22.

Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation Patients Despite Both Standard and Aggressive Supplementation.

Wallace G, Jodele S, Myers KC, Dandoy CE, El-Bietar J, Nelson A, Taggart CB, Daniels P, Lane A, Howell J, Teusink-Cross A, Davies SM.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1271-1274. doi: 10.1016/j.bbmt.2016.03.026. Epub 2016 Apr 1.

23.

Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults.

Myers KC, Howell JC, Wallace G, Dandoy C, El-Bietar J, Lane A, Davies SM, Jodele S, Rose SR.

Bone Marrow Transplant. 2016 Jul;51(7):980-4. doi: 10.1038/bmt.2016.39. Epub 2016 Mar 14.

24.

Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation.

Pate A, Rotz S, Warren M, Hirsch R, Cash M, Myers KC, El-Bietar J, Nelson A, Wallace G, Filipovich AH, Bleesing J, Chima RS, Davies SM, Jodele S, Dandoy CE.

Bone Marrow Transplant. 2016 Feb;51(2):310-2. doi: 10.1038/bmt.2015.248. Epub 2015 Oct 19. No abstract available.

25.

Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents.

Dandoy CE, Linscott LL, Davies SM, Leach JL, Myers KC, El-Bietar J, Chima RS, Pate A, Nelson A, Wallace G, Wong HR, Jodele S.

Biol Blood Marrow Transplant. 2015 Nov;21(11):2028-32. doi: 10.1016/j.bbmt.2015.07.023. Epub 2015 Jul 27.

26.

Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.

El-Bietar J, Warren M, Dandoy C, Myers KC, Lane A, Wallace G, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1994-2001. doi: 10.1016/j.bbmt.2015.06.016. Epub 2015 Jul 4.

27.

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.

Marsh RA, Rao MB, Gefen A, Bellman D, Mehta PA, Khandelwal P, Chandra S, Jodele S, Myers KC, Grimley M, Dandoy C, El-Bietar J, Kumar AR, Leemhuis T, Zhang K, Bleesing JJ, Jordan MB, Filipovich AH, Davies SM.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1460-70. doi: 10.1016/j.bbmt.2015.04.009. Epub 2015 Apr 10.

28.

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP.

Blood Rev. 2015 May;29(3):191-204. doi: 10.1016/j.blre.2014.11.001. Epub 2014 Nov 28. Review.

29.

Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.

Myers KC, Dandoy C, El-Bietar J, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2015 Feb;21(2):379-81. doi: 10.1016/j.bbmt.2014.09.026. Epub 2014 Oct 6.

30.

Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.

Dandoy CE, Davies SM, Hirsch R, Chima RS, Paff Z, Cash M, Ryan TD, Lane A, El-Bietar J, Myers KC, Jodele S.

Biol Blood Marrow Transplant. 2015 Jan;21(1):113-8. doi: 10.1016/j.bbmt.2014.09.028. Epub 2014 Oct 6.

31.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL.

Blood. 2014 Jul 24;124(4):645-53. doi: 10.1182/blood-2014-03-564997. Epub 2014 May 29.

32.

Intestinal perforation after treatment of Burkitt's lymphoma: case report and review of the literature.

Fallon SC, Redell MS, El-Bietar J, Lopez ME, Vasudevan SA, Brandt ML.

J Pediatr Surg. 2013 Feb;48(2):436-40. doi: 10.1016/j.jpedsurg.2012.12.002. Review.

PMID:
23414881
33.

Complications of transplant for nonmalignant disorders: autoimmune cytopenias, opportunistic infections, and PTLD.

Dvorak CC, Bollard CM, El-Bietar J, Filipovich A.

Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S101-10. doi: 10.1016/j.bbmt.2011.10.024. Review. No abstract available.

34.

T-cell therapies for Epstein-Barr virus-associated lymphomas.

El-Bietar J, Bollard C.

Pediatr Hematol Oncol. 2011 Nov;28(8):627-39. doi: 10.3109/08880018.2011.628367. Review.

PMID:
22023461

Supplemental Content

Loading ...
Support Center